We are pleased to announce that Dr. Kana Kajisako’s paper,
“Pathological Complete Response Achieved with Colorectal Cancer-Based Chemotherapy for Locally Recurrent Cecal Neuroendocrine Carcinoma after Surgery: A Case Report,”
has been published in Surgical Case Reports.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12872675/
This case report describes a patient with locally recurrent cecal neuroendocrine carcinoma (NEC) after surgery who achieved a pathological complete response following treatment with a colorectal cancer–based chemotherapy regimen (FOLFOXIRI plus bevacizumab).
Although colorectal NEC is extremely rare and generally associated with a poor prognosis, this case highlights the potential importance of tumor biological characteristics and serum CEA levels in guiding therapeutic decision-making.
Congratulations, Dr. Kajisako!


